SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950133-98-000289
Filing Date
1998-02-06
Accepted
1998-02-06 00:00:00
Documents
3
Group Members
BB BIOTECH AGBIOTECH TARGET S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D RE: MEDIMMUNE,INC. SC 13D/A 16967
2 JOINT FILING AGREEMENT EX-4 1482
3 SUBSCRIPTION AGREEMENT EX-5 45122
  Complete submission text file 0000950133-98-000289.txt   65870
Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Subject) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42057 | Film No.: 98524513
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000